Study of HIV Infection in the Etiology of Lung Disease (SHIELD) AIR: Air Pollution Impact on Respiratory Health in HIV

HIV 感染与肺部疾病病因学研究 (SHIELD) 空气:空气污染对 HIV 呼吸系统健康的影响

基本信息

  • 批准号:
    10664953
  • 负责人:
  • 金额:
    $ 108.12万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-08-20 至 2025-07-31
  • 项目状态:
    未结题

项目摘要

Combination antiretroviral therapy has dramatically improved survival for persons living with HIV (PLWH). With increased life expectancy, PLWH now face significant morbidity from age-related comorbidities, including greater prevalence of chronic respiratory diseases and accelerated decline in lung function. Lung injury is caused and perpetuated by noxious particles, including cigarette smoke and air pollution. Air pollution, including fine particulate matter (PM2.5) and nitrogen dioxide (NO2), has been shown to elicit inflammatory and oxidative stress responses, and is linked to impairment in lung function, development of chronic lung disease, and respiratory hospitalizations. While HIV is hypothesized to increase susceptibility to cigarette smoke, whether this extends to other pollutants remains unknown, as is the contribution of pollution to the risk for lung disease among PLWH. The Study of HIV Infection in the Etiology of Lung Disease (SHIELD) is an ongoing, prospective cohort of over 2600 individuals with or at-risk for HIV that has made significant contributions to our understanding of HIV- associated lung function impairment and respiratory morbidity. SHIELD has demonstrated that HIV leads to unique physiologic changes in the lung, including increased risk for airflow obstruction and deficiencies in gas exchange, accelerated decline in lung function, and increased respiratory morbidity. However, the contribution of environmental exposures to excess respiratory morbidity among PLWH is unknown. To address this gap, we propose to extend SHIELD to address our overarching hypothesis that PLWH represent a population that is uniquely susceptible to the health effects of air pollution and that pollutant exposure contributes to the excess lung function impairment and respiratory morbidity among PLWH. Three independent but complementary aims build upon the long-standing experience of the SHIELD cohort and add the expertise of investigators in studying health effects of outdoor and household air pollution in vulnerable populations. Aim 1 will define the impact of outdoor air pollution exposure to both acute and chronic respiratory morbidity and lung function decline among PLWH and comparable HIV-uninfected participants. Aim 2 will determine the association between household air pollution and respiratory morbidity among PLWH. Aim 3 will characterize biologic response to air pollution exposure, assessing whether HIV is associated with increased internal dose of exposure and/or exaggerated oxidative host airway and systemic response. We will apply novel approaches through molecular markers assessed with albumin adductome mass spectrometry. In all aims, we will examine how HIV and markers of HIV control influence susceptibility to pollution. Successful completion of these aims will advance our understanding of mechanisms and impact of air pollution in the setting of HIV. Further, our findings could identify therapeutic targets among high-risk populations and guide development of interventions to improve respiratory health and healthy aging among PLWH.
联合抗逆转录病毒疗法显着提高了艾滋病毒感染者 (PLWH) 的生存率。和 随着预期寿命的延长,艾滋病毒感染者现在面临着与年龄相关的合并症的显着发病率,包括更大的并发症 慢性呼吸道疾病流行,肺功能加速下降。引起肺部损伤的是 有毒颗粒,包括香烟烟雾和空气污染,使环境长期存在。空气污染,包括罚款 颗粒物 (PM2.5) 和二氧化氮 (NO2) 已被证明会引发炎症和氧化应激 反应,并与肺功能受损、慢性肺病和呼吸系统疾病的发展有关 住院治疗。虽然艾滋病毒被假设会增加对香烟烟雾的易感性,但这是否会延伸到 其他污染物仍然未知,污染对感染者肺部疾病风险的影响也是未知的。 HIV 感染与肺部疾病病因学研究 (SHIELD) 是一项持续进行的前瞻性队列研究,涵盖了超过 2600 名艾滋病毒感染者或有感染艾滋病毒风险的人为我们对艾滋病毒的了解做出了重大贡献 相关的肺功能损害和呼吸系统疾病。神盾局已证明艾滋病毒会导致 肺部独特的生理变化,包括气流阻塞和气体缺乏的风险增加 交换,加速肺功能下降,并增加呼吸道疾病发病率。然而,贡献 环境暴露导致 PLWH 呼吸道疾病发病率过高的原因尚不清楚。为了解决这一差距,我们 提议扩展 SHIELD 以解决我们的总体假设,即 PLWH 代表的人群 特别容易受到空气污染对健康的影响,并且污染物暴露会导致 PLWH 中过度的肺功能损害和呼吸系统发病率。三个独立但 互补的目标建立在神盾局团队的长期经验之上,并增加了 研究人员正在研究室外和家庭空气污染对弱势群体健康的影响。目标1 将定义室外空气污染暴露对急性和慢性呼吸道疾病和肺部疾病的影响 艾滋病病毒感染者和未感染艾滋病毒的参与者的功能下降。目标 2 将确定关联 家庭空气污染与艾滋病病毒感染者呼吸道疾病之间的关系。目标 3 将表征生物 对空气污染暴露的反应,评估艾滋病毒是否与内部暴露剂量增加有关 和/或过度的氧化宿主气道和全身反应。我们将通过以下方式应用新颖的方法 用白蛋白加合物质谱法评估分子标记。在所有目标中,我们将研究艾滋病毒如何 艾滋病毒控制的标志物影响对污染的敏感性。这些目标的成功完成将推动 我们对空气污染对艾滋病毒影响的机制和影响的理解。此外,我们的研究结果可以 确定高危人群的治疗目标并指导干预措施的制定以改善 PLWH 的呼吸健康和健康老龄化。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Reply by McCormack et al. to Townsend and Cowl, and to Miller et al.
麦考马克等人的回复
  • DOI:
  • 发表时间:
    2022-09-15
  • 期刊:
  • 影响因子:
    24.7
  • 作者:
    McCormack, Meredith;Balasubramanian, Aparna;Wise, Robert A;Keet, Corinne A;Matsui, Elizabeth C;Peng, Roger D
  • 通讯作者:
    Peng, Roger D
Race-Specific Interpretation of Spirometry: Impact on the Lung Allocation Score.
肺活量测定的种族特异性解释:对肺分配评分的影响。
  • DOI:
  • 发表时间:
    2023-10
  • 期刊:
  • 影响因子:
    8.3
  • 作者:
    Brems, J Henry;Balasubramanian, Aparna;Psoter, Kevin J;Shah, Pali;Bush, Errol L;Merlo, Christian A;McCormack, Meredith C
  • 通讯作者:
    McCormack, Meredith C
Evaluation of Calibration Approaches for Indoor Deployments of PurpleAir Monitors.
PurpleAir 监视器室内部署的校准方法评估。
  • DOI:
  • 发表时间:
    2023-10-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Koehler, Kirsten;Wilks, Megan;Green, Tim;Rule, Ana M;Zamora, Misti L;Buehler, Colby;Datta, Abhirup;Gentner, Drew R;Putcha, Nirupama;Hansel, Nadia N;Kirk, Gregory D;Raju, Sarath;McCormack, Meredith
  • 通讯作者:
    McCormack, Meredith
Reply: Disparities in Lung Transplantation: Metrics Matter.
答复:肺移植的差异:指标很重要。
  • DOI:
  • 发表时间:
    2024-02
  • 期刊:
  • 影响因子:
    8.3
  • 作者:
    Brems, J Henry;Balasubramanian, Aparna;McCormack, Meredith C
  • 通讯作者:
    McCormack, Meredith C
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gregory D Kirk其他文献

Association of immunosuppression and HIV viremia with anal cancer risk in persons living with HIV in the United States and Canada.
美国和加拿大艾滋病毒感染者的免疫抑制和艾滋病毒病毒血症与肛门癌风险的关联。
  • DOI:
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    11.8
  • 作者:
    R. Hernández;L. Qin;Haiqun Lin;W. Leyden;Romain S. Neugebauer;K. Althoff;N. Hessol;Chad J. Achenbach;J. T. Brooks;M. Gill;S. Grover;M. Horberg;Jun Li;W. C. Mathews;Á. Mayor;P. Patel;Charles S Rabkin;A. Rachlis;Amy C. Justice;Richard D. Moore;Eric A. Engels;M. Silverberg;R. Dubrow;Constance A. Benson;Ronald J. Bosch;Gregory D Kirk;Kenneth H. Mayer;C. Grasso;Robert S. Hogg;P. Richard Harrigan;J. Montaner;B. Yip;Julia Zhu;K. Salters;Karyn Gabler;K. Buchacz;Jun Li;K. Gebo;Richard D. Moore;B. Rodriguez;M. Horberg;M. Silverberg;Jennifer E. Thorne;Charles S Rabkin;Joseph B. Margolick;Lisa P. Jacobson;Gypsyamber D'Souza;M. Klein;A. Kroch;Ann N. Burchell;Adrian Betts;Joanne D. Lindsay;R. Hunter;Á. Mayor;M. John Gill;S. Deeks;Jeffrey N. Martin;J. T. Brooks;M. Saag;M. Mugavero;James Willig;W. C. Mathews;Joseph J Eron;S. Napravnik;M. Kitahata;Heidi M Crane;D. Drozd;Timothy R. Sterling;David Haas;Peter F. Rebeiro;M. Turner;Amy C. Justice;R. Dubrow;David A. Fiellin;S. Gange;K. Anastos;K. Althoff;R. Mckaig;Aimee M. Freeman;Stephen E. Van Rompaey;Liz Morton;J. McReynolds;William Lober;Jennifer S. Lee;Bin You;B. Hogan;Jinbing Zhang;Jerry Jing;E. Humes;Sally B Coburn
  • 通讯作者:
    Sally B Coburn
Designing and Validating a Novel Method for Assessing Delay Discounting Associated With Health Behaviors: Ecological Momentary Assessment Study
设计和验证一种评估与健康行为相关的延迟折扣的新方法:生态瞬时评估研究
  • DOI:
    10.2196/48954
  • 发表时间:
    2023-05-12
  • 期刊:
  • 影响因子:
    2.2
  • 作者:
    Amanda Luken;Jill A. Rabinowitz;Jonathan L Wells;D. Sosnowski;Justin C Strickland;Johannes Thrul;Gregory D Kirk;Brion S Maher
  • 通讯作者:
    Brion S Maher
Multimorbidity Among Persons Living with Human Immunodeficiency Virus in the United States
美国人类免疫缺陷病毒感染者的多重发病率
  • DOI:
    10.1093/cid/cix998
  • 发表时间:
    2018-04-03
  • 期刊:
  • 影响因子:
    11.8
  • 作者:
    Cherise Wong;S. Gange;Richard D. Moore;Amy C. Justice;K. Buchacz;A. Abraham;Peter F. Rebeiro;J. Koethe;Jeffrey N. Martin;M. Horberg;Cynthia M Boyd;M. Kitahata;H. Crane;K. Gebo;M. Gill;M. Silverberg;F. Palella;P. Patel;H. Samji;J. Thorne;Charles S Rabkin;Á. Mayor;K. Althoff;Aimee M. Freeman;A. Cescon;Anita R Rachlis;Ben Rogers;B. Rodriguez;C. Grasso;Constance A. Benson;D. Drozd;D. Fiellin;D. Haas;Gregory D Kirk;J. Willig;J. Globerman;J. Brooks;J. Eron;J. Montaner;Karyn Gabler;K. Anastos;K. Mayer;L. Jacobson;Madison Kopansky;M. Klein;M. Turner;M. Mugavero;M. Saag;P. R. Harrigan;R. Dubrow;R. Hunter;Robert S. Hogg;Ronald J. Bosch;R. Mckaig;Sally S Bebawy;S. Rourke;S. Napravnik;S. Boswell;T. Sterling
  • 通讯作者:
    T. Sterling
Baltimore oral epidemiology, disease effects, and HIV evaluation study (BEEHIVE) study protocol: a prospective cohort study
巴尔的摩口腔流行病学、疾病影响和 HIV 评估研究 (BEEHIVE) 研究方案:一项前瞻性队列研究
  • DOI:
    10.1186/s12903-024-04200-1
  • 发表时间:
    2024-04-10
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    D. Weatherspoon;Gregory D Kirk;D. Piggott;Vivek Thumbigere;Bruce A. Dye;Mark D Macek
  • 通讯作者:
    Mark D Macek
Do contemporary antiretrovirals increase the risk of end‐stage liver disease? Signals from patients starting therapy in the North American AIDS Cohort Collaboration on Research and Design
北美艾滋病队列研究与设计合作中开始治疗的患者发出的现代抗逆转录病毒药物是否会增加终末期肝病的风险?
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    2.6
  • 作者:
    Jim Young;V. Lo Re;H. Kim;Timothy R. Sterling;K. Althoff;K. Gebo;M. Gill;M. Horberg;Á. Mayor;Richard D. Moore;M. Silverberg;M. Klein;Constance A. Benson;Ronald J. Bosch;Gregory D Kirk;Vincent C Marconi;J. Colasanti;Kenneth H. Mayer;C. Grasso;Robert S. Hogg;Viviane D Lima;P. R. Harrigan;J. Montaner;B. Yip;Julia Zhu;K. Salters;K. Buchacz;Jun Li;K. Gebo;Richard D. Moore;Jeffrey Jacobson;M. Horberg;M. Silverberg;Jennifer E. Thorne;Todd Brown;Phyllis C. Tien;Gypsyamber D'Souza;Graham Smith;Mona Loutfy;Meenakshi Gupta;M. Klein;Charles Rabkin;A. Kroch;Ann N. Burchell;Adrian Betts;Joanne D. Lindsay;A. Nijhawan;Á. Mayor;M. Gill;Jeffrey N. Martin;J. T. Brooks;M. Saag;M. Mugavero;James Willig;Laura Bamford;Maile Karris;Joseph J Eron;S. Napravnik;M. Kitahata;Heidi M Crane;Timothy R. Sterling;David Haas;Peter F. Rebeiro;M. Turner;Kathleen McGinnis;Amy C. Justice;K. Althoff;S. Gange;Jennifer S. Lee;R. Mckaig;Aimee M. Freeman;Stephen E. Van Rompaey;Liz Morton;J. McReynolds;William Lober;B. Hogan;Bin You;E. Humes;R. Lang;Sally B Coburn;Lucas Gerace
  • 通讯作者:
    Lucas Gerace

Gregory D Kirk的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gregory D Kirk', 18)}}的其他基金

Baltimore Oral Epidemiology, Disease Effects, and HIV Evaluation Study (BEEHIVE)
巴尔的摩口腔流行病学、疾病影响和 HIV 评估研究 (BEEHIVE)
  • 批准号:
    10455501
  • 财政年份:
    2020
  • 资助金额:
    $ 108.12万
  • 项目类别:
Antiviral treatment as prevention for HBV- and HBV/HIV-associated hepatocellular carcinoma
抗病毒治疗预防 HBV 和 HBV/HIV 相关肝细胞癌
  • 批准号:
    10689163
  • 财政年份:
    2020
  • 资助金额:
    $ 108.12万
  • 项目类别:
H2A Developmental Core
H2A 发展核心
  • 批准号:
    10471414
  • 财政年份:
    2020
  • 资助金额:
    $ 108.12万
  • 项目类别:
Study of HIV Infection in the Etiology of Lung Disease (SHIELD) AIR: Air Pollution Impact on Respiratory Health in HIV
HIV 感染与肺部疾病病因学研究 (SHIELD) 空气:空气污染对 HIV 呼吸系统健康的影响
  • 批准号:
    10082701
  • 财政年份:
    2020
  • 资助金额:
    $ 108.12万
  • 项目类别:
HIV and HCC in Africa: The H2A Consortium
非洲的艾滋病毒和肝癌:H2A 联盟
  • 批准号:
    10084611
  • 财政年份:
    2020
  • 资助金额:
    $ 108.12万
  • 项目类别:
Antiviral treatment as prevention for HBV- and HBV/HIV-associated hepatocellular carcinoma
抗病毒治疗预防 HBV 和 HBV/HIV 相关肝细胞癌
  • 批准号:
    10259886
  • 财政年份:
    2020
  • 资助金额:
    $ 108.12万
  • 项目类别:
Research Supplements to Promote Diversity in Health-Related Research
促进健康相关研究多样性的研究补充
  • 批准号:
    10643214
  • 财政年份:
    2020
  • 资助金额:
    $ 108.12万
  • 项目类别:
Baltimore Oral Epidemiology, Disease Effects, and HIV Evaluation Study (BEEHIVE)
巴尔的摩口腔流行病学、疾病影响和 HIV 评估研究 (BEEHIVE)
  • 批准号:
    10668433
  • 财政年份:
    2020
  • 资助金额:
    $ 108.12万
  • 项目类别:
HIV and HCC in Africa: The H2A Consortium
非洲的艾滋病毒和肝癌:H2A 联盟
  • 批准号:
    10471411
  • 财政年份:
    2020
  • 资助金额:
    $ 108.12万
  • 项目类别:
H2A Admin Core
H2A 管理核心
  • 批准号:
    10689158
  • 财政年份:
    2020
  • 资助金额:
    $ 108.12万
  • 项目类别:

相似国自然基金

剪接因子U2AF1突变在急性髓系白血病原发耐药中的机制研究
  • 批准号:
    82370157
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
IKZF1-N159Y/S热点突变在急性白血病中的致病机制研究
  • 批准号:
    82300168
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
NMNAT1上调B7-H3介导急性早幼粒细胞白血病免疫逃逸的作用和机制研究
  • 批准号:
    82300169
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
支链氨基酸转氨酶1在核心结合因子急性髓细胞白血病中的异常激活与促进白血病发生的分子机制研究
  • 批准号:
    82370178
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
SRSF3/LRP5/Wnt信号通路在急性淋巴细胞白血病中的作用及机制研究
  • 批准号:
    82370128
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目

相似海外基金

Targeting P21 positive senescent cells for alleviating TMJ degeneration
靶向 P21 阳性衰老细胞减轻 TMJ 变性
  • 批准号:
    10892710
  • 财政年份:
    2023
  • 资助金额:
    $ 108.12万
  • 项目类别:
Evaluating the impacts of sea level rise on migration and wellbeing in coastal communities
评估海平面上升对沿海社区移民和福祉的影响
  • 批准号:
    10723570
  • 财政年份:
    2023
  • 资助金额:
    $ 108.12万
  • 项目类别:
GEMSSTAR PERSPIRE-COPD
GEMSSTAR 出汗-慢性阻塞性肺病
  • 批准号:
    10724784
  • 财政年份:
    2023
  • 资助金额:
    $ 108.12万
  • 项目类别:
Mechanisms underlying mustard gas-induced conjunctival injury and use of lipid mediators as medical countermeasures
芥子气引起的结膜损伤的机制以及脂质介质作为医疗对策的使用
  • 批准号:
    10882060
  • 财政年份:
    2023
  • 资助金额:
    $ 108.12万
  • 项目类别:
3/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)
3/4-美国早期肝移植联盟-前瞻性酒精相关性肝病队列评估(ACCELERATE-PACE)
  • 批准号:
    10711001
  • 财政年份:
    2023
  • 资助金额:
    $ 108.12万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了